|
1) Roth GS, Lane MA, Ingram DK, et al. Biomarkers of caloric restriction may predict longevity in humans. Science. 2002; 297: 811
|
|
|
|
2) Lane MA, Baer DJ, Tilmont EM, et al. Energy balance in rhesus monkeys (Macaca mulatta) subjected to long-term dietaryrestriction. J Gerontol A Biol Sci Med Sci. 1995; 50: B295-302
|
|
|
|
|
|
3) Heilbronn LK, de Jonge L, Frisard MI, et al. Pennington CALERIE Team. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA. 2006; 295: 1539-48
|
|
|
|
|
|
4) Imai S, Armstrong CM, Kaeberlein M, et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000; 403: 795-800
|
|
|
|
|
|
5) Tsukamoto Y, Kato J, Ikeda H. Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae. Nature. 1997; 388: 900-3
|
|
|
|
|
|
6) Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004; 305: 390-2
|
|
|
|
|
|
7) Nemoto S, Fergusson MM, Finkel T. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science. 2004; 306: 2105-8
|
|
|
|
|
|
8) North BJ, Marshall BL, Borra MT, et al. The human Sir2 ortholog, SIRT2, is an NAD＋-dependent tubulin deacetylase. Mol Cell. 2003; 11: 437-44
|
|
|
|
|
|
9) Onyango P, Celic I, McCaffery JM, et al. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci U S A. 2002; 99: 13653-8
|
|
|
|
|
|
10) Mostoslavsky R, Chua KF, Lombard DB, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006; 124: 315-29
|
|
|
|
|
|
11) Moynihan KA, Grimm AA, Plueger MM, et al. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2005; 2: 105-17
|
|
|
|
|
|
12) Picard F, Kurtev M, Chung N, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 2004; 429: 771-6
|
|
|
|
|
|
13) Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425: 191-6
|
|
|
|
|
|
14) Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006; 444: 337-42
|
|
|
|
|
|
15) Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006; 127: 1-14
|
|
|
|
|
|
16) Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007; 450: 712-6
|
|
|
|
|